博傑股份(002975.SZ):2023年度預虧4000萬元–6000萬元
格隆匯1月30日丨博傑股份(002975.SZ)公佈2023年度業績預吿,報吿期歸屬於上市公司股東的淨利潤虧損4,000.00萬元–6,000.00萬元,上年同期盈利20,201.77萬元;扣除非經常性損益後的淨利潤虧損4,200.00萬元–6,200.00萬元,上年同期盈利18,192.17萬元;基本每股收益虧損0.29元/股–0.43元/股。
2023年度歸屬於上市公司股東的預計淨利潤為負值,主要原因系報吿期內,消費電子行業市場持續疲軟,下游客户需求有所下降,致使公司收入下滑;同時公司產品技術升級,研發費用持續投入,經營成本費用上升,導致公司虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.